Effect of Verapamil on Ischemia and Ventricular Arrhythmias After an Acute Myocardial Infarction: Prognostic Implications

This article is a review of presented subsets of the Danish Verapamil Infarction Trial 11 (DAVIT II) regarding the effect of verapamil on postinfarction ischemia, ventricular arrhythmias, and heart rate (HR), and the prognostic implications of these findings. Patients underwent Holter monitoring for 24-48 h at 1 week, i.e.. before randomization to long-term treatment with placebo or verapamil, and after 1 month and about 1 year of study treatment.